OBJECTIVES OF THE MEETING

Similar documents
Gastrointestinal Oncology

OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February

Educating in Radiosurgery Course

With the Presidency of Her Majesty the Queen Sofia

Dr. Sergi Call Caja Thoracic Surgery Service

21-23 CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS CONGRESS

ConsEPOC International Meeting

HIV/HCV Coinfection in Spain: elimination is a stone's throw away

Supervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles

VASCULAR ACCESS SYMPOSIUM

Treating today s patients with tomorrow s solutions

6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:

CLINICAL CHARACTERISTICS AND OUTCOME OF HEART TRANSPLANT IN ADULTS WITH CONGENITAL HEART DISEASES

Target audience This course is directed to physicians involved in diagnosis and treatment of lysosomal diseases.

Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd

VI IMPLANTOLOGY SYMPOSIUM

Dra Amanda Iglesias, DUE Rocio Cordova, Hospital Universitario Son Espases-IdISPa,

OBESITY HYPOVENTILATION SYNDROME: CPAP vs NIV. J. F. Masa San Pedro de Alcántara Hospital Cáceres. Spain

WELCOME. Dear colleagues,

SpringerBriefs in Cancer Research

Workshop: How to tackle the obesity epidemic in European children?

April 5-6, 2016 Sabadell, Barcelona

BARIATRIC AND METABOLIC SURGERY

Gastrointestinal Oncology

III WORKSHOP INTERNATIONAL BIOCAPS 2015 (& 1st Spanish National Symposium in Incretins)

CHRONIC URTICARIA, STRIVING AND BUILDING FOR EXCELLENCE

INTERNATIONAL SYMPOSIUM

Cardiovascular Diseases (BMM9) and Getting to Know CNIC course Course

ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS

RESYNCHRONIZATION LIVE INTERACTIVE CASES WITH THE AUDIENCE. HOW TO SESSIONS.

Stroke Alliance for Europe South / West Europe Regional Conference. c/ Roc Boronat Barcelona Barcelona, 18 to 19 September 2014

FIRST CANCER CELL SIGNALING PATHWAYS MEETING

26 November Lima, Perù

II Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN)

THE PSA AND PROSTATE CANCER DILEMMA

INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT

Thursday, September 20 Registration and Poster Set-up

II CANCER CELL SIGNALING PATHWAYS CONFERENCE

Thursday, September 20 Registration and Poster Set-up

6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:

The Organizing Committee

ORGANIZED BY FUNDACIÓN GECP

V Barcelona International Congresson the. Mediterranean. Diet. Preliminar Programme March, 9, 10 and 11, 2004 in: Organized by:

ERS School Course Programme Lung Transplantation: Sharing Experience Across Europe February 23-25, 2012 Strasbourg, France

AN EPIDEMIOLOGICAL VIGILANCE STUDY OF CHEMICAL-RELATED INTOXICATIONS

Strategies to Reduce Premature Cardiovascular Morbidity and Mortality

Alpha-synuclein & Parkinson s disease Conference: Lessons from the past 20 years

Tentative Program. October 07-09, 2019 Madrid, Spain. World Congress on Nephrology. conferences/nephrology/

on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach

Barcelona Parkinson Conference

Clinical. Update in Respiratory Medicine. International Symposium on. Barcelona (Spain) February 23 rd -24 th, 2018 FINAL PROGRAMME

INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT

CHAIRMAN. - Hernán Cortés-Funes, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain FACULTY

URO. I International Workshop PEYRONIE S DISEASE UPDATED PATTERNS IN CONSERVATIVE MANAGEMENT AND SURGICAL TREATMENT OF. MADRID, 18th JUNE 2015

Dietetic supplementation of docosahexaenoic acid (DHA) in non proliferative diabetic retinopathy

2nd madrid. shoulder course. msc. MADRID - October 18-20, Chairmen: Samuel Antuña Emilio Calvo Fernando Marco

Version 1.11 of 20/07/2018

Wednesday, February 24 th, 2016

PULMONARY HYPERTENSION. by CLINICAL CASES. An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases

2 ND TRENDS IN GLAUCOMA

Welcome to the 2 nd World Bronchiectasis Conference

11th INTERNATIONAL BASIC COURSE OF FOOT & ANKLE MINIMALLY INVASIVE SURGERY

Monitoring Breathing Rate at Home Allows Early Identification of COPD Exacerbations

SEPTUA The Seven Wonders of the Shoulder

RADAR-AF Trial. A Randomized Multicenter Comparison of Radiofrequency Catheter Ablation of Drivers vs. Circumferential Pulmonary Vein

Advancing today s research; Fostering tomorrow s leaders

WPA Section on Dual Disorders/Pathology 2014 Report

FOCIS goes South: ADVANCES IN TRANSLATIONAL AND CLINICAL IMMUNOLOGY

Lisbon Foot & Ankle Clinical Biomechanics Course 2018

Dr. Eduardo Anitua MD DDS PHD. 5 Day Seminar. A biological approach to Implantology. Courses

Venezia RESPIRATORY MEDICINE NEW HORIZONS FROM THE BRIDGE OF SIGHS Ottobre. SCIENTIFIC PROGRAM

PRELIMINARY PROGRAMME. 5 edition BERLIN ORGANISING SECRETARIAT

The OncoBEAM RAS liquid biopsy experience in real-world clinical practice Frederick S. Jones, Ph.D., Global Director, Medical Scientific

The Journal of Heart and Lung Transplantation. 2007; 26(11):

Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage

BASIC & CLINICAL SCIENCE FOR THE MANAGEMENT OF THE CHRONIC PAIN PATIENT COURSE V Barcelona, November 27 th 28 th 2009

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

VASCULAR ACCESS SYMPOSIUM

Paul A. Sieving. National Eye Institute. Bethesda, MD, USA. Clinical trials of CNTF for retinitis pigmentosa

This meeting has been made possible by an independent grant from Roche.

10th INTERNATIONAL BASIC COURSE OF FOOT & ANKLE MINIMALLY INVASIVE SURGERY

21-23 ALICANTE INTERNATIONAL CONGRESS ON RESEARCH AND INNOVATION IN NEURODEGENERATIVE DISEASES CONGRESO INTERNACIONAL

BASIC COURSE OF FOOT & ANKLE ARTHROSCOPY

Treatment emergent variants to combined direct antiviral agents against hepatitis C virus


Better Prognosis for Patients With Del(7q) Than for Patients With Monosomy 7 in Myelodysplastic Syndrome

Resistencias en cáncer de mama HER2 positivo, Hay margen para la mejora?

PROGRAMME feb 2019 MADRID COURSE. 7 th MULTIDISCIPLINARY BONE AND SOFT TISSUE TUMORS MADRID COURSE. Dr. E.

Jornada sobre INVESTIGACIÓN CLÍNICA EN PEDIATRÍA. Cristina Calvo Hospital Universitario La Paz

Venezia RESPIRATORY MEDICINE NEW HORIZONS FROM THE BRIDGE OF SIGHS Ottobre. PRELIMINARY SCIENTIFIC PROGRAM

Setting The setting was a hospital. The economic study was carried out in five hospital in Spain.

Living with rare lung disease LYMPHANGIOLEIOMYOMATOSIS (LAM): The Patient Perspective. Gill Hollis, Edinburgh January 2010

The changing face of a rare disease: LAM

Report and Action Plan

PARQUE DE LAS CIENCIAS PROGRAM

PULMONARY HYPERTENSION. by CLINICAL CASES. Archiginnasio Palace

ERJ Express. Published on March 21, 2018 as doi: /

Clinical Practice Guideline on the Diagnosis, Treatment and Prevention of Tuberculosis

ESMO-Christie Lung Cancer Course

Transcription:

OBJECTIVES OF THE MEETING The Second European LAM Conference is an international meeting with the purpose of getting insights into the new results of research and sharing with patient s community and educational objectives. Working together for increasing knowledge and resources for this rare disease. Our proposal is a new challenge for patients and the professional community: the conference seeks scientific excellence from a comprehensive view focused on patient s interests in combination with educational goals not only for clinical practice but also for daily patient s life. This Second LAM Conference is integrated with the Rare Respiratory Disease Year s activities program by The Spanish Society of Pulmonology and Thoracic Surgery. ORGANIZED BY AELAM and SEPAR

Dr Eusebi Chiner Secretary of SEPAR, Hospital Univ. San Juan, Alicante Dr Estrella Fernández President of SEPAR Congress Committee, Hospital Univ. Dr Peset, Valencia Dr Beatriz Lara Coordinator of the SEPAR Year of Rare Respiratory Disease, Hospital Univ. Arnau de Vilanova, Lleida Dr Antonio Román Hospital Univ. Vall d Hebron, Barcelona Mrs Mª Luz Vila President of AELAM and Coordinator of the SEPAR Year of Rare Respiratory Disease, Vigo Mrs Claudia Delgado Director of FEDER, Spanish Federation of Rare Disease, Madrid

15.00/16.00 Registration 16.00/18.00 CLINICAL INSIGHTS OF LAM Session Chairs: E Henske and P Ussetti 16.00/16.30 Lessons from LAM F McCormack, MD 16.30/17.00 LAM Guidelines for doctors and patients, what is the next step? V Cottin, MD, PhD 17.00/17.30 Clinical and Cellular Phenotyping in LAM: Identification of Patient and LAM Cell Subtypes J Moss, MD, PhD 17.30/18.00 Discussion 18.00/18.30 WELCOME AND INAUGURAL ACT Major of Barcelona, Honorable Mr Xavier Trias President of SEPAR, Dr Pilar de Lucas President of AELAM and Coordinator of SEPAR ERM Year, Mrs Mª Luz Vila 18.30/20.00 PATIENTS SESSION. ONGOING ACTIONS FOR PATIENTS Session Chairs: ML Vila and I Bassi 18.30/18.45 Spanish handbook for LAM patients A Romero, MD, and M Lupon, DUE 18.45/19.00 Spanish registry of LAM ISCIII-SEPAR A Casanova, MD 19.00/19.30 European LAM Federation I Bassi 19.30/20.00 Discussion 20.00 WELCOME COCKTAIL

09.00/13.00 BIOLOGY OF LAM Session Chairs: J Moss and MA Pujana 09.00/09.30 Metastatic properties and cellular origin of LAM MA Pujana, PhD 09.30/10.00 Genetics of LAM, TSC mutations E Henske, MD 10.00/10.30 mtor signalin and future treatments F McCormack, MD 10.30/11.00 Discussion 11.00/11.30 Coffee break 11.30 /12.00 Vascular effects of Estrogens C Hermenegildo, PhD 12.00/ 12.30 Animal model in LAM V Krymskaya, PhD 1230 /1300 Discussion 13.00/14.30 LUNCH

14.30 /16.30 ONGOING LAM TRIALS: THE FUTURE HOPE FOR PATIENTS Session Chairs: V Krymskaya and A Roman 14.30/15.00 Doxycycline S Johnson, MD 15.00/15.30 Sirolimus and Letrozol F McCormack, MD 15.30/16.00 Sirolimus and Hydroxychloroquine E Henske, MD 16.00/16.30 Discussion 16.30/17.00 Coffee break 17.00/18.15 LUNG TRANSPLANTATION AS LAST STEP TODAY AND REPARATION FOR TOMORROW Session Chairs: B Lara and S Johnson 17.00/17.30 Lung Transplantation in LAM A Román, MD 17.30/18.00 Lung Regeneration R Farré, PhD 18.00/18.15 Discussion 18.15/18.45 CLOSE

PARTICIPANTS Iris Bassi. President of LAM Italia Álvaro Casanova, MD. Pulmonology Department. Hospital Universitario del Henares, Madrid Vincent Cottin, MD, PhD. Hôpital cardiovasculaire et pneumologique Louis Pradel, Bron, France Ramón Farré, PhD.CIBERES. Facultad de Medicina Universidad de Barcelona Elisabeth Henske, MD. Brigham and Women s Hospital, Boston USA Carlos Hermenegildo, PhD. INCLIVA Fundación Investigación Hospital Clínico de Valencia Simon Johnson, MD. Nottingham University Hospital, UK Vera Krymskaya, PhD. University of Pennsylvania, USA Beatriz Lara, MD. Coordinator of the SEPAR Year of Rare Respiratory Disease, Pulmonology Department. Hospital Universitari Arnau de Vilanova, Lleida Meritxell Lupón. DUE, Barcelona Francis McCormack, MD. University of Cincinnati Medical Center, USA Joel Moss, MD, PhD. NHLBI - National Institutes of Health. Bethesda, USA Miguel Ángel Pujana, PhD. Institut Català d'oncologia IDIBELL, Barcelona Antonio Román, MD. Unidad de Trasplante Pulmonar, Servicio de Neumología. Hospital Universitario Vall d Hebron, Barcelona Ana Romero, MD. Hospital Universitario Virgen de las Nieves, Granada Piedad Ussetti, MD. Pulmonology Department. Hospital Universitario Puerta de Hierro, Madrid MªLuz Vila. President of AELAM and Coordinator of the SEPAR Year of Rare Respiratory Disease, Vigo